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Summary
Objectives: CCN family 2/connective tissue growth factor (CCN2/CTGF) is an atypical growth factor for growth plate chondrocytes. It plays an
important role in their proliferation and differentiation in vitro, but does not stimulate hypertrophy or calciﬁcation of articular chondrocytes. We
herein report for the ﬁrst time that CCN2/CTGF promotes growth and differentiation of auricular chondrocytes and maintains their molecular
phenotype in vitro and in vivo.
Methods: Auricular chondrocytes were isolated from rabbit auricular cartilage by trypsinecollagenase treatment, and treated with human
recombinant CCN2/CTGF or infected with adenovirus harboring the ccn2/ctgf gene. Cell proliferation was measured by [3H] thymidine incor-
poration and MTS assay, and changes in gene expression of auricular chondrocyte markers were monitored by real-time polymerase chain
reaction , Northern hybridization, and histological analysis. For in vivo studies, auricular chondrocytes were cultured as pellets and implanted
subcutaneously after treatment of recombinant human CCN2/CTGF. Ectopically formed cartilage was subjected to histological analysis. Cell
death was monitored by in situ TUNEL analysis.
Results: CCN2/CTGF stimulated proliferation, differentiation and synthesis of elastin and proteoglycans of rabbit primary auricular chondro-
cytes in a dose-dependent manner. CCN2/CTGF caused a 2.5-fold increase in the expression of elastin in comparison to the control, resulting
in enhanced deposition of elastin ﬁbers in a monolayer culture of auricular chondrocytes. Mineralization was not induced; in contrast, CCN2/
CTGF stimulated expression of matrix gla protein which is known to impair mineralization. Furthermore, pretreatment of pellets of auricular
chondrocytes with CCN2/CTGF and subcutaneous implantation signiﬁcantly enhanced the growth of ectopic auricular cartilage pieces
expressing phenotypic markers of auricular chondrocytes including type II and X collagen. Notably, chondrocyte apoptosis was impaired
by CCN2/CTGF.
Conclusions: These ﬁndings show that CCN2/CTGF may be a suitable agent for promoting differentiation and growth of auricular chondro-
cytes, while preventing mineralization and apoptosis, and suggests that CCN2/CTGF may be useful for the repair or reconstruction of elastic
cartilage.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Abbreviations: CCN2/CTGF, CCN family 2/connective tissue growth factor, MTS 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium, TUNEL terminal uridine deoxynucleotidyl transferase dUTP nick end labeling, EDTA ethylenedinitrilotetra-
acetic acid, RT-PCR reverse transcriptase-mediated polymerase chain reaction, aMEMminimum essential medium (MEM) alpha modiﬁcation,
FBS fetal bovine serum, CPC cetylpyridinium chloride, M-MLV moloney murine leukemia virus, PBS phosphate buffered saline, IgG Immu-
nogloburin G, MGP matrix gla protein.Introduction
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787cartilage, especially in hypertrophic chondrocytes1,2, and
promotes cell proliferation, maturation, and hypertrophy of
growth plate chondrocytes2. It also promotes proliferation
and maturation of articular chondrocytes in vitro, but it
does not induce their hypertrophy or calciﬁcation3. These
ﬁndings indicate that CCN2/CTGF may reinforce the spe-
ciﬁc phenotypes of chondrocytes derived from different
types of cartilage. However, there is scant information con-
cerning the role of CCN2/CTGF in the differentiation and
phenotypic stability of auricular chondrocytes. Auricular car-
tilage is classiﬁed as elastic cartilage, which in contrast to
hyaline cartilage, expresses elastin in addition to type II,
X, IX and XI collagen and chondroitin sulfate proteoglycan
as major matrix constituents4,5. Elastin is responsible for
the enhanced elasticity of auricular cartilage in comparison
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Fig. 1. rhCCN2/CTGF enhances the proliferation of rabbit auricular
chondrocytes in a dose-dependent manner. (A) Auricular chondro-
cytes were grown in aMEM containing 10% FBS until sub conﬂu-
ence, and the medium was subsequently changed to aMEM
containing 0.5% FBS. After 24 h of incubation, the cells were treated
with rhCCN2/CTGF at the indicated concentrations for 24 h. PBS
was added to control cultures. The cells were labeled with [3H] thy-
midine during the last 4 h. (B) MTS assay for cell proliferation show-
ing an enhanced number of rabbit auricular chondrocytes after 5 and
7 days of treatment with rhCCN2/CTGF. Auricular chondrocytes
were grown in aMEM containing 10% FBS for 24 h, and the medium
was changed to aMEM containing 0.5% FBSwith (black columns) or
without (open columns) rhCCN2/CTGF (50 ng/ml).
788 T. Fujisawa et al.: CCN2 stimulates auricular chondrocytesto hyaline cartilage4. In this study, we have investigated the
effects of CCN2/CTGF on auricular chondrocytes and dem-
onstrated that CCN2/CTGF promotes the differentiation,
matrix synthesis, and growth while inhibiting mineralization.
Therefore, CCN2/CTGF may be useful for improving the
reconstruction of elastic cartilage in vivo and in tissue
engineering.Materials and methodsISOLATION AND CULTURES OF CHONDROCYTESRabbit chondrocytes were isolated from auricular cartilage of 4-week-old
male Japanese white rabbits as previously described, with some modiﬁca-
tions6. Brieﬂy, rabbit auricular cartilage was dissected from the perichon-
drium and diced into small pieces. The cartilage specimens were then
treated with 0.5% trypsin solution containing 0.02% EDTA. The chondro-
cytes were released by digestion with 0.075% collagenase (collagenase
type I, GIBCO BRL, Grand Island, NY, USA) in aMEM (Sigma, St Louis,
MO, USA) containing 5% FBS (JRH, Lenexa, KS, USA) and ﬁltered through
a 100 mm nylon ﬁlter (FALCON, Flanklin Lakes, NJ, USA). The cells were
seeded at a density of 2.5 104 cells/cm2 into 6-cm diameter dishes or
24-, 48-, or 96-well multiplates in aMEM containing 10% FBS and cultured
in 5% CO2 in air at 37
C.ADENOVIRUS-MEDIATED GENE TRANSFECTIONRecombinant adenoviruses that express CCN2/CTGF or LacZ were pre-
pared, and adenovirus-mediated gene transfection (10 moi) was performed
as described previously2.DETERMINATION OF DNA SYNTHESISRabbit auricular chondrocytes were cultured in 24-well multiplates with
aMEM containing 10% FBS until they reached subconﬂuence. The cells
were preincubated with the same medium containing 0.5% FBS for 24 h and
were then further incubated in the same medium in the presence or absence
of recombinant human (rh) CCN2/CTGF (30, 50 or 100 ng/ml) for another
24 h. They were labeled with [3H] thymidine (37 MBq/ml) at a ﬁnal concentra-
tion of 370 kBq/ml for the ﬁnal 4 h. After labeling, the cells were harvested, and
[3H] thymidine incorporation was measured in a scintillation counter.MTS ASSAYRabbit auricular chondrocytes were plated into 96-well multiplates with
aMEM containing 10% FBS and cultured for 24 h. The cells were washed
once with serum-free aMEM, and the media were subsequently replaced
with aMEM containing 0.5% FBS in the presence or absence of rhCCN2/
CTGF (50 ng/ml). After several days culture (as indicated in Fig. 1), the ef-
fect of rhCCN2/CTGF on cell proliferation was determined using the MTS
[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium, inner salt; MTS] assay (CellTiter 96 AQueous One Solu-
tion; Promega, Madison, WI, USA) according to the manufacturer’s protocol.DETERMINATION OF PROTEOGLYCAN SYNTHESISRabbit auricular chondrocytes were cultured in 48-well multiplates with
aMEM containing 10% FBS until they reached conﬂuence. Proteoglycan
synthesis was determined as originally described by Takigawa et al.7 and
modiﬁed by Fujisawa et al.6. Brieﬂy, the cells were preincubated with se-
rum-free aMEM for 24 h; the media were replaced by aMEM with or without
rhCCN2/CTGF (30, 50 or 100 ng/ml) and the cells were incubated for an-
other 22 h. Labeling with [35S] sulfate (37 MBq/ml) at a ﬁnal concentration
of 370 kBq/ml was done for 17 h. After labeling, the cells were washed,
and the cultures were digested with 1 mg/ml actinase E for digestion of
core proteins for 21 h at 55C. The radioactivity of the material precipitated
with cetylpyridinium chloride (CPC) was measured in a scintillation counter.RNA ISOLATION, QUANTITATIVE REAL-TIME REVERSE
TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR),
AND NORTHERN HYBRIDIZATIONTotal RNA was isolated using TRIZOL reagent (GIBCO BRL) from conﬂu-
ent cultures of rabbit auricular chondrocytes treated with or without 50 ng/ml
of rhCCN2/CTGF for 48 h, or chondrocytes infected with adenoviruses har-
boring ccn2/ctgf or lacZ for 96 h2. Reverse transcription was performed for
30 min at 42C with 1 mg of total RNA as above, oligo d(T)16 primer and
M-MLV reverse transcriptase (Perkin Elmer, Branchburg, NJ, USA). The re-
sulting cDNA was diluted and aliquots were ampliﬁed in triplicates by the
SYBR Green PCR assay (LightCycler system [Roche Diagnostics, Man-
nheim, Germany]) with LightCycler-FastStart DNA Master SYBR Green I kit
(Roche) for 18s, MGP, and elastin, and SYBR Green Realtime PCR Master
Mix (TOYOBO, Osaka, Japan) for ccn2/ctgf, col2a1, and col10a1. PCRs
were done by incubation for 15 min at 95C followed by 50 ampliﬁcation
cycles with 30 s denaturation at 95C, 40 s annealing at an indicated temper-
ature in Table I, and 40 s extension at 74C. An 18S was used to standardize
the total amount of cDNA. The sequences of primers for ccn2/ctgf, elastin,
col2a1, col10a1, and matrix gla protein (MGP) are shown in Table I.
The speciﬁcity of PCR was checked by annealing melting curves and by
electrophoresis of the amplicons. The relative mRNA levels were determined
by comparing the PCR cycle threshold (1) between cDNA of the gene of in-
terest and of 18S and (2) between target and control conditions. For control,
subcloned cDNAs were used in this study.
Northern hybridization was done as described previously (Hattori et al.8). A
probe speciﬁc formgp was prepared from RNA of rabbit chondrocytes by RT-
PCRusingmgpprimers (50-ATGAAGAGCCTGCTCCCTCTGGCCATCCTG-30
and 50-ATATTTGGCTCCTCGGCGCTGCCTGAAGTAG-30).DETECTION OF ELASTIC FIBERSThe production of elastic ﬁbers was evaluated by Victoria Blue stain-
ing. Rabbit auricular chondrocytes were cultured for 24 h in 48-well multi-
plates with aMEM containing 10% FBS. The medium was subsequently
Table I
The sequences of each primer sets
Annealing temperature ((C)
18S rRNA Sense GCGAATTCCTGCCAGTAGCATATGCTTG 58
Antisense GGAAGCTTAGAGGAGCGAGCGACCAAAGG
Elastin Sense GGTGTGGGRGTGCTCCCTGGAGTTCCC 60
Antisense TTGATGGGATAMCCCAGTGGGAC
CCN2 Sense GCAGGCTAGAGAAGCAGAGC
Antisense ATGTCTTCATGCTGGTGCAG 60
col2a1 Sense GACCCCATGCAGTACATGCG 62
Antisense AGCCGCCATTGATGGTCTCC
col10a1 Sense TGAGAGGAGAACAAGGTATTCCTGGA 50
Antisense TTTCCCCTTTCTGTCCACTCACACCA
MGP Sense ACGAAAGCATGGAGTCCTATGAA 60
Antisense TGTAGTCATCGCAGGCCTCTC
789Osteoarthritis and Cartilage Vol. 16, No. 7replaced with aMEM containing 0.5% FBS in the absence or presence of
rhCCN2/CTGF (50 ng/ml) and the chondrocytes were cultured for another
14 days (replacing the media every 3 days). After the culturing, the cells
were ﬁxed with 95% ethanol for 5 min at room temperature, washed three
times with PBS, and stained with Victoria Blue overnight at room
temperature.MINERALIZATION ASSAYIn order to detect calcium mineral deposition in auricular chondrocyte cul-
ture, culture dishes were stained by Alizarin Red. Rabbit auricular chondro-
cytes were cultured for 24 h in 48-well multiplates with aMEM containing
10% FBS. The medium was subsequently replaced with aMEM containing
0.5% FBS in the presence or absence of rhCCN2/CTGF (50 ng/ml) every
3 days and cultured for 28 days. The cells were ﬁxed with 95% ethanol for
15 min at room temperature, washed three times with PBS, and stained
with 1% Alizarin Red for 15 min at room temperature.IN VIVO IMPLANTATION AND HISTOLOGICAL ANALYSISRabbit auricular chondrocytes (2 106 cells) were centrifuged at 500g in
15 ml conical tubes and the pellets were cultured in aMEM containing 10%
FBS in 5% CO2 in air at 37
C. The medium was changed every 3 days. After
3 weeks of incubation, the pellets were immersed in PBS with or without
10 mg/ml of rhCCN2/CTGF for 1 h. We then implanted the pellets in subcuta-
neous pockets in 6-week old nude mice (4 pellets/animal). Four weeks after
implantation these pellets were ﬁxed in 4% paraformaldehyde overnight at
4C for histological analysis, embedded in parafﬁn, and sliced into 5 mm thick[
3
5
S
]
s
u
l
f
a
t
e
 
i
n
c
o
r
p
o
r
a
t
i
o
n
(
x
 
1
0
4
 
c
p
m
/
w
e
l
l
)
0
10
15
20
25
#
**
0 30 50 100
Concentration of rhCCN2/CTGF (ng/ml)
5
Fig. 2. rhCCN2/CTGF enhances proteoglycan synthesis of rabbit
auricular chondrocytes in a dose-dependent manner. Rabbit auric-
ular chondrocytes were cultured until conﬂuence in aMEM contain-
ing 10% FBS, changed to a medium with serum-free aMEM, and
incubated for another 24 h. rhCCN2/CTGF was added to the media
at the indicated concentrations, and the cells were incubated for
22 h and labeled with [35S] sulfate for the ﬁnal 17 h. [35S] sulfate
was incorporated into CPC-precipitable materials and was
measured after digestion with actinase E.sections. The sections were stained with safranin Oefast green and alcian
blue (pH 2.5) for proteoglycans9 and with Victoria Blue for elastic ﬁbers.
For immunohistochemical analysis, the sections were incubated with anti
types I, II, and III collagen (Fuji Chemical Industries, Tokyo, Japan) and
a monoclonal anti type X collagen X5310 (kindly provided by Dr von der
Mark, University of Erlangen, Germany) at 1:100 dilutions for primary anti-
bodies and anti-mouse IgG conjugated to horseradish peroxidase (DAKO,
Cambridge, UK) at 1:500 dilution. Signals were detected by TrueBlue perox-
idase substrate (Zymed, South San Francisco, CA, USA) or DAB (3,30-diami-
nobenzidine tetrahydrochloride, Sigma) substrate. All staining processes
were performed at room temperature.TUNEL ASSAYApoptotic cells were detected by TUNEL assay with an In Situ Cell Death
Detection Kit (Roche) according to the manufacturer’s instructions.STATISTICAL ANALYSISIf not stated otherwise, experiments were repeated at least three times.
Statistical analysis was performed by an unpaired t test or a ManneWhitney
U test. Data are expressed as the mean standard deviation (SD).ResultsEFFECTS OF CCN2/CTGF ON PROLIFERATION OF RABBIT
AURICULAR CHONDROCYTES IN CULTURErhCCN2/CTGF stimulated the proliferation of auricular
chondrocytes, as measured by [3H] thymidine incorporation
in a dose-dependent manner [Fig. 1(A)]. At 50 ng/ml,
rhCCN2/CTGF induced a 1.5-fold increase in DNA synthe-
sis in comparison to the PBS-treated control. There was no
signiﬁcant further enhancement of [3H] thymidine incorpora-
tion at 100 ng/ml of rhCCN2/CTGF compared to 50 ng/ml.
Accordingly, the cell number as measured by MTS assay
was also slightly enhanced by CCN2/CTGF after 5 and 7
days [Fig. 1(B)].EFFECT OF CCN2/CTGF ON PROTEOGLYCAN SYNTHESIS IN
RABBIT AURICULAR CHONDROCYTES IN CULTURETo determine the effect of CCN2/CTGF on proteoglycan
synthesis, rabbit auricular chondrocytes were treated with
increasing amounts of rhCCN2/CTGF. As shown in Fig. 2,
rhCCN2/CTGF stimulated the incorporation of [35S] sulfate
in a dose-dependent manner, indicating enhanced proteo-
glycan synthesis. At 50 ng/ml of rhCCN2/CTGF, the proteo-
glycan synthesis in rabbit auricular chondrocytes was 1.4
times higher than in the control.
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Fig. 3. rhCCN2/CTGF enhances the expression of ccn2/ctgf, elastin, and col2a1, but does not enhance the expression of col10a1. (AeD)
Rabbit auricular chondrocytes were treated with or without rhCCN2/CTGF (50 ng/ml) for 48 h in aMEM containing 0.5% FBS. The total
RNA was isolated, and ccn2/ctgf (A), elastin (B), col2a1 (C), and col10a1 mRNA (D) were measured by real-time RT-PCR, and each value
was standardized to 18S rRNA. (E) Elastic ﬁbers were stained with Victoria Blue after 14 days of incubation with rhCCN2/CTGF (50 ng/ml).
(F) The cells were stained by Alizarin Red after 28 days of incubation with rhCCN2/CTGF (50 ng/ml).
790 T. Fujisawa et al.: CCN2 stimulates auricular chondrocytesEFFECTS OF CCN2/CTGF ON AURICULAR CHONDROCYTE
DIFFERENTIATION IN CULTUREThe inﬂuence of CCN2/CTGF on auricular chondrocyte
differentiation markers was investigated by measuring levels
of type II collagen (col2a1), type X collagen (col10a1) and
elastin (elastin) mRNA by real-time RT-PCR. Interestingly,
after stimulation with 50 ng/ml rhCCN2/CTGF for 48 h,
mRNA levels of ccn2/ctgf were increased up to 1.9 times
over control levels [Fig. 3(A)]. Elastin mRNA was enhanced
about 5-fold [Fig. 3(B)] and col2a1 mRNA was enhanced
about 1.5-fold [Fig. 3(C)]. The expression of the col10a1
gene which is the major marker of chondrocyte hypertrophy
was also slightly enhanced by rhCCN2/CTGF [Fig. 3(D)], al-
though the enhancement was not signiﬁcant. Furthermore,
the extracellular deposition of elastin ﬁber was signiﬁcantlyenhanced after treatment with rhCCN2/CTGF for 14 days
[Fig. 3(E)].EFFECT OF CCN2/CTGF ON CALCIFICATION AND MGP
EXPRESSION IN AURICULAR CHONDROCYTESIn order to test whether CCN2/CTGF affects calciﬁcation
of auricular cartilage, cultures of auricular chondrocytes
were stained with Alizarin Red after treatment with
rhCCN2/CTGF for 28 days. As shown in Fig. 3(F), CCN2/
CTGF did not enhance the mineralization of auricular
chondrocytes. In contrast, both the adenoviral overexpres-
sion of CCN2/CTGF and the treatment of rhCCN2/CTGF
stimulated the expression of MGP in auricular chondrocytes
[Fig. 4(A) and (B)]. Since MGP has been shown to act as
MGP
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Fig. 4. CCN2/CTGF stimulates MGP mRNA expression in auricular chondrocytes. (A) Auricular chondrocytes were infected with AdCCN2 or
AdLacZ (10 moi) for 96 h, and total RNA was collected. RNAs were subjected to Northern blotting and hybridized with a probe for MGP. (B)
Auricular chondrocytes were infected with AdCCN2 (10 moi) or treated with rhCCN2/CTGF (50 ng/ml). After 48 h of incubation, the RNAs were
collected and subjected to real-time PCR using MGP-speciﬁc primers.
791Osteoarthritis and Cartilage Vol. 16, No. 7a negative regulator of calciﬁcation11, it is possible that
CCN2/CTGF may protect the auricular chondrocytes from
mineralization by stimulating MGP synthesis.EFFECT OF CCN2/CTGF ON IN VIVO GROWTH OF AURICULAR
CARTILAGE IMPLANTSTo investigate the inﬂuence of CCN2/CTGF on differentia-
tion and cartilage tissue formation of auricular chondrocytes
in vivo, rabbit auricular chondrocyteswere cultured as pellets
for 3 weeks, soaked in either PBS or rhCCN2/CTGF solution
(10 mg/ml) for 1 h, and implanted under the skin of nude
mice. Four weeks after implantation, the chondrocyte pellets
were harvested and analyzed. The pieces of ectopic carti-
lage formed by rhCCN2/CTGF-treated chondrocyte pellets
were reproducibly larger in comparison to the control group
[Fig. 5(A)]. Measurement of the dry weight of the implants
showed enhanced growth of cartilage tissue as a result of
the rhCCN2/CTGF treatment [Fig. 5(D)]. Histological evalua-
tion of proteoglycan synthesis by safranin O [Fig. 5(B) and
(C)], alcian blue [Fig. 5(EeH)], and type II collagen staining
[Fig. 5(I) and (J)] conﬁrmed the chondrocytic phenotype of
both the control and rhCCN2/CTGF-treated ectopic cartilage
implants. Type X collagen staining showed a slightly en-
hanced reaction for this collagen in rhCCN2/CTGF-treated
cartilage implants as compared to PBS-treated implants
[Fig. 5(K) and (L)]. Elastic ﬁber deposition as visualized by
Victoria Blue staining, however, was only marginally en-
hanced [Fig. 5(M) and (N)].
Immunohistochemical staining using anti type I and III
collagen antibodies did not show any positive staining in
both the control and rhCCN2/CTGF-treated ectopic carti-
lage implants (data not shown), indicating that no signiﬁcant
chondrocyte dedifferentiation had occurred. These ﬁndings
therefore demonstrate a signiﬁcant growth stimulation of ec-
topic auricular chondrocyte implants which were pretreatedwith rhCCN2/CTGF in pellet culture and the stabilization of
the elastic cartilage phenotype by rhCCN2/CTGF.PROTECTION FROM APOPTOSIS BY CCN2/CTGF ON
IMPLANTED AURICULAR CARTILAGEThe histological analysis of ectopic cartilage pieces
showed a rather low density of chondrocytes, while in
rhCCN2/CTGF-treated cartilage samples, the cell density
was much higher. We therefore examined the rates of cell
apoptosis in CCN2/CTGF-treated and control explant cul-
tures, using the TUNEL assay. The analysis revealed the
cell apoptosis rates to be strongly inhibited by rhCCN2/
CTGF [Fig. 6(AeC)].Discussion
Abundant literature exists concerning the regulation of
proliferation, differentiation, and matrix synthesis of hyaline
chondrocytes by growth factors and hormones, but rela-
tively little is known about the regulation of these functions
in auricular chondrocytes. CCN2/CTGF is thought to be an
‘‘atypical’’ growth factor. It stimulates proliferation and differ-
entiation, hypertrophy and calciﬁcation in growth plate
chondrocytes, but not in articular chondrocytes12e15, but
a speciﬁc receptor for CCN2 has not yet been clearly iden-
tiﬁed. In this study, we demonstrated, for the ﬁrst time, that
the DNA synthesis of auricular chondrocytes can be stimu-
lated by CCN2/CTGF. [3H] thymidine incorporation in mono-
layer cultures of auricular chondrocytes was signiﬁcantly
enhanced by CCN2/CTGF, and the cell numbers measured
after several days in rhCCN2/CTGF-treated cultures were
found to have increased.
In addition, proteoglycan synthesismeasuredby sulfate in-
corporation, as well as the gene expression and extracellular
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793Osteoarthritis and Cartilage Vol. 16, No. 7deposition of elastin and type II collagen were signiﬁcantly
enhanced by CCN2/CTGF. Another notable ﬁnding was
that CCN2/CTGF stimulated its own gene expression.
Therefore, CCN2/CTGF may be a suitable growth factor to
improve the proliferation and matrix synthesis of auricular
chondrocytes.
Major problems of tissue engineering of elastic cartilage
are undesired hypertrophy and mineralization of the repair
tissue. We have previously reported that CCN2/CTGF
stimulates the gene expression of type X collagen in
growth plate cartilage2, but not in articular cartilage3. In
auricular chondrocytes, the induction of col10a1 expression
in the rhCCN2/CTGF-treated cultures was not signiﬁcant
[Fig. 3(D)], while some enhancement of type X collagen ac-
cumulation was seen in ectopic pellets after the treatment
with CCN2/CTGF [Fig. 5(K) and (L)]. Interestingly, rabbit au-
ricular chondrocytes treated with rhCCN2/CTGF showed no
marked mineralization [Fig. 3(F)], but enhanced expression
ofmgp (Fig. 4). MGP is a 14 kDa extracellular matrix protein
of mineral-binding gla protein family. Studies of MGP-
deﬁcient mice suggest that MGP to be an inhibitor ofFig. 5. rhCCN2/CTGF enhances the subcutaneous growth of auricular ch
Rabbit auricular chondrocytes (2 106 cells) were centrifuged, cultured a
and immersed in PBS with or without rhCCN2/CTGF (10 mg/ml) for 1 h.
(4 pellets/animal) and analyzed 4 weeks after implantation. This ﬁgure d
out of six samples (three controls and three rhCCN2/CTGF-treated sam
(right) harvested pellets from the implant cultures after 3 weeks in mice
and (C) rhCCN2/CTGF-treated implant cultures. (D) Dry weight of the imp
Alcian blue staining of PBS-treated (E) and rhCCN2/CTGF-treated (F) ha
shown in (E) and (F), respectively. (I, J): Type II collagen staining of PBS-
(K, L): Type X collagen staining of PBS-treated (K) and rhCCN2/CTGF-tr
PBS-treated (M) and rhCCN2/CTGF-treaextracellular matrix calciﬁcation in the arteries and the epi-
physial growth plate leading to a short stature, osteopenia,
and enhanced bone fractures16. Moreover, constitutively
expressed MGP impairs endochondral and intermembra-
nous ossiﬁcation in the limb11. ATDC5 cultures show the
expression of MGP to be required during endochondral os-
siﬁcation and chondrocyte survival17. Our result suggests
that CCN2/CTGF may negatively control calciﬁcation of
auricular chondrocytes by enhancing MGP levels. There-
fore the CCN2/CTGF treatment of auricular chondrocytes
may be a suitable way to prevent calciﬁcation in tissue
engineering.
A major challenge in cartilage tissue engineering is to ob-
tain sufﬁcient cell numbers without loss of their phenotype.
van Osch et al.18 reported a decrease in elastin expression
and morphological changes in auricular chondrocytes after
expansion in monolayer culture. We herein demonstrated
that CCN2/CTGF not only enhances auricular chondrocyte
expansion, but also contributes to the maintenance of the
chondrogenic phenotype by stimulating the expression of
elastin, type II collagen and proteoglycans. Furthermore,ondrocyte pellets and supports the maintenance of the phenotype.
s pellets in 15 ml tubes in aMEM containing 10% FBS for 3 weeks,
The pellets were implanted in subcutaneous pockets in nude mice
epicts sections of two representative ectopic cartilage specimens
ples) analyzed. (A) PBS-treated (left) and rhCCN2/CTGF-treated
. Bar: 1 mm. Histological evaluation by safranin O of the (B) PBS
lant cultures (two controls and two rhCCN2/CTGF-treated samples).
rvested implanted pellets. (G, H): High magniﬁcation of the inserts
treated (I) and rhCCN2/CTGF-treated (J) harvested implant pellets.
eated (L) harvested implant pellets. (M, N): Victoria blue staining of
ted (N) harvested implant pellets.
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Fig. 6. rhCCN2/CTGF inhibits apoptotic cell death in auricular chondrocyte implants. Chondrocyte implants without (A) or with (B) treatment of
rhCCN2/CTGF were prepared as in Fig. 5. The sections were analyzed by TUNEL assay, and positive cells were counted in 10 different ﬁelds
of 400 300 mm2 (C).
794 T. Fujisawa et al.: CCN2 stimulates auricular chondrocytesCCN2/CTGF reduces apoptosis rates in ectopic auricular
cartilage implants. Therefore, CCN2/CTGF is considered
to be useful for expanding the number of cells with their
phenotypes.
In conclusion, we have provided evidence that CCN2/
CTGF may be a suitable factor to promote the phenotype
of auricular chondrocytes by enhancing cell proliferation,
proteoglycan synthesis, elastin and type II collagen expres-
sion, as well as elastin ﬁber accumulation in vitro. In combi-
nation with our in vivo results, these ﬁndings indicate that
CCN2/CTGF may be useful for the repair and reconstruc-
tion of elastic cartilage such as auricular cartilage.Acknowledgments
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